Table: SymBio Pharmaceuticals -2025 group results

SymBio Pharmaceuticals

05/02/2026 06:32

Feb 5 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Dec 31, 2025    Dec 31, 2024    Dec 31, 2026      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           1.31            2.45            3.89                   
               (-46.7 pct)     (-56.1 pct)    (+197.5 pct)               
  Operating     loss 4.44       loss 3.88       loss 4.23                
  Recurring     loss 4.65       loss 3.69       loss 4.29                
  Net
  Net           loss 4.78       loss 3.83       loss 4.33                
  EPS        loss 95.12 yen  loss 85.00 yen  loss 72.81 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - SymBio Pharmaceuticals Limited.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T